Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation | 2014
Lenalidomide maintenance for high-risk multiple myeloma after allogeneic hematopoietic cell transplantation.
Alsina M, Becker PS, Zhong X, Adams A, Hari P, Rowley S, Stadtmauer EA, Vesole DH, Logan B, Weisdorf D, Qazilbash M, Popplewell LL, McClune B, Bensinger W, Riches M, Giralt SA, Pasquini MC
PubMed
PMID: 24769014
Abstract
Related Articles
CIBMTR Study #: 07-REV